[
  {
    "variant_id": "rs429358",
    "gene": "APOE",
    "disease": "Alzheimer's Disease",
    "impact_score": 87,
    "predictions": {
      "expression": {
        "APOE": -0.87,
        "TOMM40": -0.23
      },
      "chromatin": {
        "astrocytes": -0.45,
        "microglia": 0.02,
        "neurons": 0.01
      },
      "splicing": {
        "exon_skip": 0.12,
        "cryptic_site": 0.08
      },
      "tf_binding": {
        "CTCF": -0.67,
        "SPI1": -0.12
      }
    },
    "interpretation": "**Primary Mechanism**: Significant down-regulation of APOE expression mediated by chromatin remodeling in astrocytes.\n**Key Evidence**:\n- Predicted expression decrease of 0.87 Δ in the APOE promoter region.\n- High cell-type specificity (0.90) for astrocytes, suggesting localized CNS impact.\n- Disruption of CTCF binding sites indicates a loss of topological insulation.\n**Biological Impact**: Strong association with Late-Onset Alzheimer's Disease (LOAD) through impaired lipid transport.\n**Confidence**: High (Precomputed Validation)\n**Validation Recommendation**: Conduct ChIP-seq to verify disrupted CTCF recruitment in astrocytes.",
    "cell_specificity": {
      "astrocytes": 0.9,
      "microglia": 0.1,
      "neurons": 0.05
    },
    "contact_maps": {
      "enhancer_promoter_loop_strength": -0.34
    }
  },
  {
    "variant_id": "rs129349",
    "gene": "TCF7L2",
    "disease": "Type 2 Diabetes",
    "impact_score": 64,
    "predictions": {
      "expression": {
        "TCF7L2": -0.42,
        "ACSML": -0.05
      },
      "chromatin": {
        "liver": -0.31,
        "pancreas": -0.52,
        "muscle": 0.02
      },
      "splicing": {
        "exon_skip": 0.34,
        "cryptic_site": 0.01
      },
      "tf_binding": {
        "HNF4A": -0.45,
        "FOXA2": -0.28
      }
    },
    "interpretation": "**Primary Mechanism**: Moderate regulatory disruption of TCF7L2 expression via pancreatic-specific enhancer hijacking.\n**Key Evidence**:\n- 0.52 Δ shift in chromatin accessibility specifically in pancreatic islets.\n- Significant increase in exon-skipping (34%), potentially creating a non-functional isoform.\n- Reduced affinity for HNF4A transcription factor complex.\n**Biological Impact**: Increased risk of Type 2 Diabetes via impaired glucose-stimulated insulin secretion.\n**Confidence**: High (Precomputed Validation)\n**Validation Recommendation**: Perform Minigene assay to quantify exon-skipping ratio.",
    "cell_specificity": {
      "pancreas": 0.85,
      "liver": 0.45,
      "muscle": 0.1
    },
    "contact_maps": {
      "enhancer_promoter_loop_strength": -0.56
    }
  },
  {
    "variant_id": "rs113488022",
    "gene": "BRCA1",
    "disease": "Breast Cancer",
    "impact_score": 92,
    "predictions": {
      "expression": {
        "BRCA1": -1.2,
        "NBR2": -0.1
      },
      "chromatin": {
        "breast_epithelium": -0.88,
        "ovary": -0.42
      },
      "splicing": {
        "exon_skip": 0.78,
        "cryptic_site": 0.45
      },
      "tf_binding": {
        "MYC": -0.72,
        "E2F1": -0.54
      }
    },
    "interpretation": "**Primary Mechanism**: Severe functional knockdown of BRCA1 via catastrophic splicing failure and promoter silencing.\n**Key Evidence**:\n- Extreme expression loss (-1.2 Δ) in breast epithelial tissue.\n- Massive exon-skipping (78%) predicted to cause a premature stop codon (PTC).\n- Disruption of the E2F1-mediated transcription hub.\n**Biological Impact**: Extremely high risk for Hereditary Breast and Ovarian Cancer (HBOC) syndrome.\n**Confidence**: High (Precomputed Validation)\n**Validation Recommendation**: Urgent mRNA-seq and protein quantification (Western Blot).",
    "cell_specificity": {
      "breast_epithelium": 0.95,
      "ovary": 0.7,
      "liver": 0.05
    },
    "contact_maps": {
      "enhancer_promoter_loop_strength": -0.89
    }
  }
]